secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2023-03-06T23:59:59+00:00
Accession:  0001606498-23-000023
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos Medical appoints Dr. Lisa Egbuonu-Davis to board of directors
--------------------------------------------------------------------

- Dr. Egbuonu-Davis appointed as independent director effective March 6, 2023; serves on Compliance and Governance Committees.
- She receives $70,000 annual cash retainer, $7,500 Compliance Committee fee, $5,000 Governance Committee fee, and $190,000 in RSUs.
- Board now comprises six directors: five independent, two women, one ethnically diverse.
- Egbuonu-Davis is VP Medical Innovations at DH Diagnostics (Danaher affiliate); previously VP at Sanofi and roles at Pfizer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000023/0001606498-23-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000023/avns-20230228.htm
  HTML page:      https://secwatch.observer/filing/0001606498-23-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer